Physician profile
Steven Rivero
NPI 1447646468
$9,142.04
in general payments reported to CMS, 2019-2025
8 companies · $1,367 in 2025
The $1,367 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,823 · 2022: $3,045 · 2023: $238 · 2024: $1,668 · 2025: $1,367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,010 · Travel and Lodging: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,009.88 |
| Travel and Lodging | $1,264.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,205.16 | 2021-2025 | Gamma, T2 Alpha, Pro-Dense |
| Exactech, INC. | $889.73 | 2022-2025 | |
| Depuy Synthes Sales INC. | $855.46 | 2021-2025 | Na, Fibulink |
| Synthes Gmbh | $551.04 | 2022 | |
| Medical Device Business Services, INC. | $415.77 | 2021-2025 | Na |
| Smith+Nephew, INC. | $104.89 | 2022 | |
| Osteocentric Technologies, INC. | $99.24 | 2021 | |
| Solventum Corporation | $20.75 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena Restor Axioform, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Rivero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.